Movapo: Apomorphine belongs to the class of medications called anti-Parkinson's agents. It is used to treat the early return of stiffness and movement problems that occur when the effects of other medications for Parkinson's disease wear off early.

MOVAPO PFS is a pre-diluted, pre-filled syringe intended for use as a continuous infusion with a suitable pump/syringe driver. There is no need to dilute MOVAPO PFS prior to use.

Apomorphine hydrochloride is a potent post-synaptic dopamine agonist. The Health Canada–approved indication for apomorphine is for treatment of acute, intermittent hypomobility “off” episodes (“end-of-dose wearing off” and unpredictable “on/off”) in patients with advanced PD.

APO-go ® /MOVAPO [®/] 注射液是治疗帕金森的一种常规疗法。 帕金森疾病的特征是脑中含多巴胺的神经元出现进行性退化，进而导致患者丧失运动控制能力。

MOVAPO Injection is a clear, colourless or almost colourless sterile solution for injection, practically free from visible particles with a pH of 3.0 – 4.0. MOVAPO Injection is indicated to reduce the number and severity of ‘off’ phases in patients with Parkinson’s disease severely disabled by motor fluctuations refractory to conventional therapy.

Apomorphine hydrochloride, a synthetic derivative of morphine without any of the narcotic and opiate effects of the parent compound, is marketed in Canada as Movapo. It is formulated in 2 mL ampoules or 3 mL pre-filled disposable multi-dose pens with a concentration of 10 mg/mL.

MOVAPO and MOVAPO PFS are used in the treatment of Parkinson's disease to reduce the number and severity of bouts of freezing and stiffness (or “off” periods).

To perform a systematic review of the beneficial and harmful effects of apomorphine hydrochloride injection (Movapo) for the acute, intermittent treatment of hypomobility “off” episodes (“end-of-dose wearing off” and unpredictable “on/off” episodes) in …

Movapo® is indicated for the acute, intermitent treatment of hypomobility, “OFF episodes (“end-of-dose wearing off and unpredictable “ON/OFF” episodes) in patients with advanced Parkinson’s disease. It is an apomorphine hydrochloride injection (10 mg/mL), supplied as pre-filled pens.

2022年10月11日 · Apomorphine is usually used for more advanced Parkinson's when other treatments no longer work well to control Parkinson's symptoms on their own. It is used if you have sudden and unpredictable changes in your symptoms or have severe ‘off’ periods.